Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.» Read More
Oct 27- Amgen Inc on Monday reported higher-than-expected third quarter profit and revenue, helped by strong demand for its white blood cell booster, Neulasta, and increased sales of newer drugs, and the company raised its full-year forecast. Amgen shares are up almost 20 percent since the restructuring announcement that involved plant closings and the...
Oct 24- Amgen Inc, one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund. In a letter to investors on Tuesday, Loeb said Amgen has "all the hallmarks of a hidden value situation" and should divide...
*IBM slumps after quarterly results. NEW YORK, Oct 20- U.S. stocks ended higher on Monday on investor hopes for a strong earnings season, but IBM's disappointing results limited gains. IBM shares slumped 7.1 percent to $169.10, the biggest drag on both the Dow and S&P 500, after third-quarter earnings fell well short of Wall Street expectations.
All too often, investors throw out the proverbial baby with the bathwater. Cramer would hate to see some of them lost down the drain.
An undercurrent that’s been sorely missing from the stock market resurfaced on Wednesday. Cramer thinks you should factor it into your next move.
If you’re looking for stock ideas, Cramer says thanks to good ol’ American ingenuity, this sector is bursting with them.
Check out which companies are making headlines after the bell Tuesday:Bed Bath & Beyond, Viacom, Starbucks & more.
Jim Cramer is always looking near and far for ideas. He just found something big.
Cramer thinks pros are so eager to buy Alibaba they’re willing to throw away perfectly good stocks. That’s silly.
As the Alibaba IPO nears, Cramer expects a slew of stocks to selloff. He's naming names.
Stocks cut losses to close mixed on Thursday as geopolitical tensions lingered ahead of consumer data.
NEW YORK, Sept 11- U.S. stocks were lower on Thursday, with biotechnology shares among the weakest of the day as investors continued to take profits. Celgene Corp was the biggest decliner on the S&P 500, off 3 percent at $91.28, while Vertex Pharmaceuticals was down 2.3 percent at $92.60.
Three biotech stocks have plenty of potential, John Schroer of Allianz Global Investors says.
The dynamics in the market are changing. And Cramer says investors need to change, accordingly.
Goldman Sachs and Asian tech name, Baidu were in the "buy" category, while Netflix and utilities exchange-traded fund XLU were among the stocks to "sell."
The stock market has been able to bounce back from every negative headline and set fresh record highs. But, some stocks have fared better than others.
Some of Wednesday's midday movers:
Apple touched a fresh high Wednesday along with a handful of other companies:
Some of Tuesday's midday movers:
Cramer often look inside the market for insights on broad sentiment. And certain things happened on Wednesday that suggest trouble.